199 related articles for article (PubMed ID: 16249454)
1. Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals.
Dalla Man C; Campioni M; Polonsky KS; Basu R; Rizza RA; Toffolo G; Cobelli C
Diabetes; 2005 Nov; 54(11):3265-73. PubMed ID: 16249454
[TBL] [Abstract][Full Text] [Related]
2. beta-Cell function and insulin sensitivity in adolescents from an OGTT.
Sunehag AL; Man CD; Toffolo G; Haymond MW; Bier DM; Cobelli C
Obesity (Silver Spring); 2009 Feb; 17(2):233-9. PubMed ID: 19057529
[TBL] [Abstract][Full Text] [Related]
3. Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion.
Cretti A; Lehtovirta M; Bonora E; Brunato B; Zenti MG; Tosi F; Caputo M; Caruso B; Groop LC; Muggeo M; Bonadonna RC
Eur J Clin Invest; 2001 May; 31(5):405-16. PubMed ID: 11380592
[TBL] [Abstract][Full Text] [Related]
4. Incretin action maintains insulin secretion, but not hepatic insulin action, in people with impaired fasting glucose.
Perreault L; Man CD; Hunerdosse DM; Cobelli C; Bergman BC
Diabetes Res Clin Pract; 2010 Oct; 90(1):87-94. PubMed ID: 20708814
[TBL] [Abstract][Full Text] [Related]
5. β-Cell Function and Insulin Sensitivity in Youth With Early Type 1 Diabetes From a 2-Hour 7-Sample OGTT.
Galderisi A; Evans-Molina C; Martino M; Caprio S; Cobelli C; Moran A
J Clin Endocrinol Metab; 2023 May; 108(6):1376-1386. PubMed ID: 36546354
[TBL] [Abstract][Full Text] [Related]
6. Insulin secretion rate and beta-cell sensitivity from oral glucose tolerance test in normotensive and normoglycemic humans.
Di Nardo F; Cerasa P; Casagrande F; Boemi M; Morosini P; Burattini R
Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():449-50. PubMed ID: 17945585
[TBL] [Abstract][Full Text] [Related]
7. Measures of beta-cell function during the oral glucose tolerance test, liquid mixed-meal test, and hyperglycemic clamp test.
Bacha F; Gungor N; Arslanian SA
J Pediatr; 2008 May; 152(5):618-21. PubMed ID: 18410762
[TBL] [Abstract][Full Text] [Related]
8. Insulin action and secretion in hypertension in the absence of metabolic syndrome: model-based assessment from oral glucose tolerance test.
Burattini R; Di Nardo F; Casagrande F; Boemi M; Morosini P
Metabolism; 2009 Jan; 58(1):80-92. PubMed ID: 19059535
[TBL] [Abstract][Full Text] [Related]
9. Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity.
Breda E; Cavaghan MK; Toffolo G; Polonsky KS; Cobelli C
Diabetes; 2001 Jan; 50(1):150-8. PubMed ID: 11147781
[TBL] [Abstract][Full Text] [Related]
10. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
[TBL] [Abstract][Full Text] [Related]
11. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.
Okuno Y; Komada H; Sakaguchi K; Nakamura T; Hashimoto N; Hirota Y; Ogawa W; Seino S
Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440
[TBL] [Abstract][Full Text] [Related]
12. Development and assessment of the disposition index based on the oral glucose tolerance test in subjects with different glycaemic status.
Santos JL; Yévenes I; Cataldo LR; Morales M; Galgani J; Arancibia C; Vega J; Olmos P; Flores M; Valderas JP; Pollak F
J Physiol Biochem; 2016 Jun; 72(2):121-31. PubMed ID: 26660757
[TBL] [Abstract][Full Text] [Related]
13. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach.
Xu L; Man CD; Charbonnel B; Meninger G; Davies MJ; Williams-Herman D; Cobelli C; Stein PP
Diabetes Obes Metab; 2008 Dec; 10(12):1212-20. PubMed ID: 18476982
[TBL] [Abstract][Full Text] [Related]
14. Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients.
Henriksen JE; Alford F; Ward GM; Beck-Nielsen H
Diabetologia; 1997 Dec; 40(12):1439-48. PubMed ID: 9447952
[TBL] [Abstract][Full Text] [Related]
15. Assessment of insulin sensitivity and secretion with the labelled intravenous glucose tolerance test: improved modelling analysis.
Mari A
Diabetologia; 1998 Sep; 41(9):1029-39. PubMed ID: 9754821
[TBL] [Abstract][Full Text] [Related]
16. A model of GLP-1 action on insulin secretion in nondiabetic subjects.
Dalla Man C; Micheletto F; Sathananthan A; Rizza RA; Vella A; Cobelli C
Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1115-21. PubMed ID: 20179243
[TBL] [Abstract][Full Text] [Related]
17. A stable isotope method for in vivo assessment of human insulin synthesis and secretion.
Jainandunsing S; van Miert JNI; Rietveld T; Darcos Wattimena JL; Sijbrands EJG; de Rooij FWM
Acta Diabetol; 2016 Dec; 53(6):935-944. PubMed ID: 27552831
[TBL] [Abstract][Full Text] [Related]
18. Epinephrine exerts opposite effects on peripheral glucose disposal and glucose-stimulated insulin secretion. A stable label intravenous glucose tolerance test minimal model study.
Avogaro A; Toffolo G; Valerio A; Cobelli C
Diabetes; 1996 Oct; 45(10):1373-8. PubMed ID: 8826974
[TBL] [Abstract][Full Text] [Related]
19. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test.
Mari A; Pacini G; Murphy E; Ludvik B; Nolan JJ
Diabetes Care; 2001 Mar; 24(3):539-48. PubMed ID: 11289482
[TBL] [Abstract][Full Text] [Related]
20. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test.
Retnakaran R; Shen S; Hanley AJ; Vuksan V; Hamilton JK; Zinman B
Obesity (Silver Spring); 2008 Aug; 16(8):1901-7. PubMed ID: 18551118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
